This inventor holds 6 USPTO granted patents and 5 published patent applications and 9 EPO patents. Top assignees: Flamel Technologies, Adocia. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2020
Title: Rémi Soula: Innovator in Protein Formulation and Insulin Solutions
Introduction
Rémi Soula is a prominent inventor based in Lyons, France, recognized for his groundbreaking contributions to the field of biochemistry and pharmaceuticals. With six patents to his name, he has developed innovative solutions that enhance the solubility and effectiveness of proteins, particularly in the realm of rapid-acting insulin formulations.
Latest Patents
Rémi's latest inventions include an aqueous composition that features at least one protein and one solubilizing agent. This liquid composition comprises proteins in an aqueous medium, combined with anionic compounds containing aromatic nuclei and a specific molar mass range. This invention not only offers a novel way to solubilize proteins but also outlines a process to achieve effective solubilization.
Another significant patent involves a rapid-acting insulin formulation that includes an oligosaccharide. This composition is designed to facilitate faster insulin absorption, utilizing oligosaccharides with a distinct degree of polymerization and specific properties that enhance the formulation's overall effectiveness.
Career Highlights
Throughout his career, Rémi Soula has collaborated with esteemed companies, notably Flamel Technologies and Adocia. His work at these organizations has positioned him as a leader in the innovation of pharmaceutical formulations, contributing significantly to advances in medical treatments.
Collaborations
Rémi has had the pleasure of working alongside talented individuals such as Gérard Soula and Olivier Soula. These collaborations have fostered a creative environment where innovative ideas can flourish, leading to the successful development of groundbreaking inventions.
Conclusion
In summation, Rémi Soula's inventive spirit and dedication to enhancing biopharmaceutical products have led to significant advancements in solubility and insulin delivery systems. His work not only paves the way for improved medical treatments but also exemplifies the impact of inventive thinking in the realm of science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile